Caricamento...
Is endocan a novel potential biomarker of liver steatosis and fibrosis?
BACKGROUND: Studies that evaluated endocan levels in nonalcoholic fatty liver disease (NAFLD) and liver fibrosis are scarce. We aimed to explore endocan levels in relation to different stages of liver diseases, such as NAFLD, as determined with fatty liver index (FLI) and liver fibrosis, as assessed...
Salvato in:
| Pubblicato in: | J Med Biochem |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Society of Medical Biochemists of Serbia, Belgrade
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7682781/ https://ncbi.nlm.nih.gov/pubmed/33269025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/jomb-2019-0042 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|